Radiotherapy and radiosurgery for benign skull base meningiomas.
Meningiomas located in the region of the base of skull are difficult to access. Complex combined surgical approaches are more likely to achieve complete tumor removal, but frequently at a cost of treatment related high morbidity. Local control following subtotal excision of benign meningiomas can be improved with conventional fractionated external beam radiation therapy with a reported 5-year progression-free survival up to 95%. New radiation techniques, including stereotactic radiosurgery (SRS), fractionated stereotactic radiotherapy (FSRT), and intensity-modulated radiotherapy (IMRT) have been developed as a more accurate technique of irradiation with more precise tumor localization, and consequently a reduction in the volume of normal brain irradiated to high radiation doses. SRS achieves a high tumour control rate in the range of 85-97% at 5 years, although it should be recommended only for tumors less than 3 cm away more than 3 mm from the optic pathway because of high risk of long-term neurological deficits. Fractionated RT delivered as FSRT, IMRT and protons is useful for larger and irregularly or complex-shaped skull base meningiomas close to critical structures not suitable for single-fraction SRS. The reported results indicate a high tumour control rate in the range of 85-100% at 5 years with a low risk of significant incidence of long-term toxicity. Because of the long natural history of benign meningiomas, larger series and longer follow-up are necessary to compare results and toxicity of different techniques.
Minniti
Giuseppe
G
Department of Radiotherapy Oncology, Sant' Andrea Hospital, University La Sapienza, Rome, Italy. gminniti@ospedalesantandrea.it
Amichetti
Maurizio
M
Enrici
Riccardo Maurizi
RM
D002986:Clinical Trials as Topic; D006801:Humans; D008579:Meningioma / Q000532:radiotherapy* / Q000601:surgery*; D016634:Radiosurgery / Q000379:methods; D011878:Radiotherapy / Q000379:methods; D019292:Skull Base Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D016896:Treatment Outcome